|
Iris Oifigiúil |
GA Sraith C |
|
C/2024/910 |
31.1.2024 |
Achoimre ar chinntí an Aontais Eorpaigh maidir le húdaruithe margaíochta i ndáil le táirgí íocshláinte ó 1 Nollaig 2023 go dtí 31 Nollaig 2023
(Arna fhoilsiú de bhun Airteagal 13 nó Airteagal 38 de Rialachán (CE) Uimh. 726/2004 ó Pharlaimint na hEorpa agus ón gComhairle (1) nó Airteagal 5 de Rialachán (AE) 2019/6 ó Pharlaimint na hEorpa agus ón gComhairle (2))
(C/2024/910)
— Údarú margaíochta a eisiúint (Airteagal 13 de Rialachán (CE) Uimh. 726/2004 ó Pharlaimint na hEorpa agus ón gComhairle): Glactha
|
Dáta an chinnidh |
Ainm an táirge íocshláinte |
ANI (an tAinm Neamhdhílseánaigh Idirnáisiúnta) |
Sealbhóir an údaraithe margaíochta |
Uimhir na hiontrála sa Chlár Comhphobail |
Foirm chógaisíochta |
An Cód CAT (an Cód Ceimiceach Teiripeach Anatamaíoch) |
Dáta an fhógra |
||
|
1.12.2023 |
Zilbrysq |
zilucoplan |
|
EU/1/23/1764 |
Tuaslagán le haghaidh insteallta |
L04A |
4.12.2023 |
||
|
7.12.2023 |
ELREXFIO |
elranatamab |
|
EU/1/23/1770 |
Tuaslagán le haghaidh insteallta |
Pending |
8.12.2023 |
||
|
7.12.2023 |
Elucirem |
gadaphicleanóil |
|
EU/1/23/1772 |
Tuaslagán le haghaidh insteallta |
V08CA |
8.12.2023 |
||
|
7.12.2023 |
JEMPERLI |
dostarlimab |
|
EU/1/21/1538 |
Tiúchán do thuaslagán le haghaidh insilte |
L01FF07 |
11.12.2023 |
||
|
7.12.2023 |
Veoza |
fezolinetant |
|
EU/1/23/1771 |
Piolla brataithe le scannán |
G02CX06 |
12.12.2023 |
||
|
7.12.2023 |
Vueway |
gadaphicleanóil |
|
EU/1/23/1773 |
Tuaslagán le haghaidh insteallta |
V08CA12 |
8.12.2023 |
||
|
13.12.2023 |
Dimethyl Fumarate Accord |
dimethyl fumarate |
|
EU/1/22/1711 |
Capsúl gastrai-fhrithsheasmhach, crua |
L04AX07 |
13.12.2023 |
||
|
13.12.2023 |
Dimethyl fumarate Mylan |
fúmaráit démheitile |
|
EU/1/22/1634 |
Capsúl gastrai-fhrithsheasmhach, crua |
L04AX07 |
13.12.2023 |
||
|
13.12.2023 |
Dimethyl fumarate Neuraxpharm |
fúmaráit démheitile |
|
EU/1/22/1637 |
Capsúl gastrai-fhrithsheasmhach, crua |
L04AX07 |
16.12.2023 |
||
|
13.12.2023 |
Dimethyl fumarate Polpharma |
fúmaráit démheitile |
|
EU/1/22/1635 |
Capsúl gastrai-fhrithsheasmhach, crua |
L04AX07 |
13.12.2023 |
||
|
13.12.2023 |
Dimethyl Fumarate Teva |
n/a |
|
EU/1/22/1702 |
Capsúl gastrai-fhrithsheasmhach, crua |
L04AX07 |
15.12.2023 |
||
|
14.12.2023 |
AGAMREE |
vamorolone |
|
EU/1/23/1776 |
Fuaidreán béil |
|
15.12.2023 |
||
|
15.12.2023 |
Loargys |
pegzilarginase |
|
EU/1/23/1774 |
Solution for injection or infusion |
A16AB24 |
18.12.2023 |
||
|
22.12.2023 |
Rezzayo |
Rezafungin |
|
EU/1/23/1775 |
Púdar do thiúchán do thuaslagán le haghaidh insilte |
J02AX08 |
22.12.2023 |
— Údarú margaíochta a mhodhnú (Airteagal 13 de Rialachán (CE) Uimh. 726/2004 ó Pharlaimint na hEorpa agus ón gComhairle): Glactha
|
Dáta an chinnidh |
Ainm an táirge íocshláinte |
Sealbhóir an údaraithe margaíochta |
Uimhir na hiontrála sa Chlár Comhphobail |
Dáta an fhógra |
||
|
1.12.2023 |
Bemfola |
|
EU/1/13/909 |
5.12.2023 |
||
|
1.12.2023 |
Beyfortus |
|
EU/1/22/1689 |
4.12.2023 |
||
|
1.12.2023 |
Clopidogrel Krka |
|
EU/1/09/556 |
5.12.2023 |
||
|
1.12.2023 |
Dificlir |
|
EU/1/11/733 |
4.12.2023 |
||
|
1.12.2023 |
Vaxelis |
|
EU/1/15/1079 |
4.12.2023 |
||
|
1.12.2023 |
Vizamyl |
|
EU/1/14/941 |
6.12.2023 |
||
|
1.12.2023 |
VPRIV |
|
EU/1/10/646 |
6.12.2023 |
||
|
7.12.2023 |
Ammonaps |
|
EU/1/99/120 |
8.12.2023 |
||
|
7.12.2023 |
Atazanavir Krka |
|
EU/1/19/1353 |
14.12.2023 |
||
|
7.12.2023 |
Benepali |
|
EU/1/15/1074 |
12.12.2023 |
||
|
7.12.2023 |
Besremi |
|
EU/1/18/1352 |
11.12.2023 |
||
|
7.12.2023 |
Byooviz |
|
EU/1/21/1572 |
12.12.2023 |
||
|
7.12.2023 |
CARVYKTI |
|
EU/1/22/1648 |
11.12.2023 |
||
|
7.12.2023 |
Erleada |
|
EU/1/18/1342 |
11.12.2023 |
||
|
7.12.2023 |
Fasturtec |
|
EU/1/00/170 |
8.12.2023 |
||
|
7.12.2023 |
Febuxostat Krka |
|
EU/1/18/1347 |
14.12.2023 |
||
|
7.12.2023 |
Fluad Tetra |
|
EU/1/20/1433 |
13.12.2023 |
||
|
7.12.2023 |
Flucelvax Tetra |
|
EU/1/18/1326 |
14.12.2023 |
||
|
7.12.2023 |
Hemgenix |
|
EU/1/22/1715 |
15.12.2023 |
||
|
7.12.2023 |
Imatinib Accord |
|
EU/1/13/845 |
11.12.2023 |
||
|
7.12.2023 |
Intrarosa |
|
EU/1/17/1255 |
8.12.2023 |
||
|
7.12.2023 |
Jardiance |
|
EU/1/14/930 |
11.12.2023 |
||
|
7.12.2023 |
Lyrica |
|
EU/1/04/279 |
12.12.2023 |
||
|
7.12.2023 |
Neupro |
|
EU/1/05/331 |
8.12.2023 |
||
|
7.12.2023 |
Omnitrope |
|
EU/1/06/332 |
11.12.2023 |
||
|
7.12.2023 |
Posaconazole Accord |
|
EU/1/19/1379 |
11.12.2023 |
||
|
7.12.2023 |
Pregabalin Pfizer |
|
EU/1/14/916 |
12.12.2023 |
||
|
7.12.2023 |
Steglatro |
|
EU/1/18/1267 |
8.12.2023 |
||
|
7.12.2023 |
Striascan |
|
EU/1/19/1372 |
8.12.2023 |
||
|
7.12.2023 |
Sycrest |
|
EU/1/10/640 |
10.12.2023 |
||
|
7.12.2023 |
Symkevi |
|
EU/1/18/1306 |
8.12.2023 |
||
|
7.12.2023 |
Tecartus |
|
EU/1/20/1492 |
12.12.2023 |
||
|
7.12.2023 |
Tecovirimat SIGA |
|
EU/1/21/1600 |
8.12.2023 |
||
|
7.12.2023 |
TECVAYLI |
|
EU/1/22/1675 |
11.12.2023 |
||
|
7.12.2023 |
TOOKAD |
|
EU/1/17/1228 |
11.12.2023 |
||
|
7.12.2023 |
Vizimpro |
|
EU/1/19/1354 |
8.12.2023 |
||
|
7.12.2023 |
Vyepti |
|
EU/1/21/1599 |
11.12.2023 |
||
|
7.12.2023 |
Xevudy |
|
EU/1/21/1562 |
11.12.2023 |
||
|
11.12.2023 |
AYVAKYT |
|
EU/1/20/1473 |
12.12.2023 |
||
|
11.12.2023 |
Brineura |
|
EU/1/17/1192 |
12.12.2023 |
||
|
11.12.2023 |
Erelzi |
|
EU/1/17/1195 |
15.12.2023 |
||
|
11.12.2023 |
Evkeeza |
|
EU/1/21/1551 |
12.12.2023 |
||
|
11.12.2023 |
KEYTRUDA |
|
EU/1/15/1024 |
12.12.2023 |
||
|
11.12.2023 |
Mounjaro |
|
EU/1/22/1685 |
13.12.2023 |
||
|
11.12.2023 |
Moventig |
|
EU/1/14/962 |
12.12.2023 |
||
|
11.12.2023 |
Nepexto |
|
EU/1/20/1436 |
13.12.2023 |
||
|
11.12.2023 |
Pedea |
|
EU/1/04/284 |
12.12.2023 |
||
|
11.12.2023 |
Pradaxa |
|
EU/1/08/442 |
12.12.2023 |
||
|
11.12.2023 |
Ventavis |
|
EU/1/03/255 |
12.12.2023 |
||
|
14.12.2023 |
AMGEVITA |
|
EU/1/16/1164 |
18.12.2023 |
||
|
14.12.2023 |
Enbrel |
|
EU/1/99/126 |
19.12.2023 |
||
|
14.12.2023 |
NexoBrid |
|
EU/1/12/803 |
21.12.2023 |
||
|
14.12.2023 |
Pepaxti |
|
EU/1/22/1669 |
15.12.2023 |
||
|
18.12.2023 |
Clopidogrel Taw Pharma |
|
EU/1/09/559 |
19.12.2023 |
||
|
18.12.2023 |
Clopidogrel Viatris |
|
EU/1/09/568 |
21.12.2023 |
||
|
19.12.2023 |
Amvuttra |
|
EU/1/22/1681 |
20.12.2023 |
||
|
19.12.2023 |
Ibandronic Acid Teva |
|
EU/1/10/642 |
21.12.2023 |
||
|
19.12.2023 |
Kalydeco |
|
EU/1/12/782 |
20.12.2023 |
||
|
19.12.2023 |
Rinvoq |
|
EU/1/19/1404 |
20.12.2023 |
||
|
19.12.2023 |
Tacforius |
|
EU/1/17/1244 |
8.1.2024 |
||
|
19.12.2023 |
Tevimbra |
|
EU/1/23/1758 |
22.12.2023 |
— Údarú margaíochta a tharraingt siar (Airteagal 13 de Rialachán (CE) Uimh. 726/2004 ó Pharlaimint na hEorpa agus ón gComhairle)
|
Dáta an chinnidh |
Ainm an táirge íocshláinte |
Sealbhóir an údaraithe margaíochta |
Uimhir na hiontrála sa Chlár Comhphobail |
Dáta an fhógra |
||
|
11.12.2023 |
Onbevzi |
|
EU/1/20/1499 |
13.12.2023 |
— Údarú margaíochta a mhodhnú (Airteagal 38 de Rialachán (CE) Uimh. 726/2004 ó Pharlaimint na hEorpa agus ón gComhairle; Airteagal 5 de Rialachán (AE) 2019/6 ó Pharlaimint na hEorpa agus ón gComhairle): Glactha
|
Dáta an chinnidh |
Ainm an táirge íocshláinte |
Sealbhóir an údaraithe margaíochta |
Uimhir na hiontrála sa Chlár Comhphobail |
Dáta an fhógra |
||
|
11.12.2023 |
Advocate |
|
EU/2/03/039 |
12.12.2023 |
||
|
18.12.2023 |
Baycox Iron |
|
EU/2/19/239 |
20.12.2023 |
||
|
19.12.2023 |
Credelio Plus |
|
EU/2/21/271 |
21.12.2023 |
||
|
19.12.2023 |
ERAVAC |
|
EU/2/16/199 |
20.12.2023 |
||
|
19.12.2023 |
ERYSENG |
|
EU/2/14/166 |
21.12.2023 |
||
|
19.12.2023 |
Evalon |
|
EU/2/16/194 |
20.12.2023 |
||
|
19.12.2023 |
EVANT |
|
EU/2/18/233 |
21.12.2023 |
||
|
19.12.2023 |
Hiprabovis IBR Marker Live |
|
EU/2/10/114 |
21.12.2023 |
||
|
19.12.2023 |
Leucogen |
|
EU/2/09/096 |
20.12.2023 |
||
|
19.12.2023 |
Meloxoral |
|
EU/2/10/111 |
20.12.2023 |
||
|
19.12.2023 |
MHYOSPHERE PCV ID |
|
EU/2/20/259 |
20.12.2023 |
||
|
19.12.2023 |
Nobivac LeuFel |
|
EU/2/17/217 |
20.12.2023 |
||
|
19.12.2023 |
Nobivac Myxo-RHD PLUS |
|
EU/2/19/244 |
21.12.2023 |
||
|
19.12.2023 |
RHINISENG |
|
EU/2/10/109 |
22.12.2023 |
||
|
19.12.2023 |
STARTVAC |
|
EU/2/08/092 |
22.12.2023 |
||
|
19.12.2023 |
Suvaxyn Circo |
|
EU/2/17/223 |
21.12.2023 |
||
|
19.12.2023 |
Suvaxyn Circo + MH RTU |
|
EU/2/15/190 |
21.12.2023 |
||
|
19.12.2023 |
UBAC |
|
EU/2/18/227 |
21.12.2023 |
Aon duine ar mian leis féachaint ar an tuarascáil mheasúnaithe phoiblí maidir leis na táirgí íocshláinte atá i gceist agus na cinntí a bhaineann léi, iarrtar orthu teagmháil a dhéanamh le:
|
European Medicines Agency |
|
Domenico Scarlattilaan 6 |
|
1083 HS Amsterdam |
|
NETHERLANDS |
ELI: http://data.europa.eu/eli/C/2024/910/oj
ISSN 1977-107X (electronic edition)